Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

CUSIP: 702712100

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
-25,793
Put/Call ratio
4.8%
SEC-reported price per share
$0.79
Number of holders
41
Value change
-$250,391
Number of buys
10
Open additional details 1 more signal available
Number of sells
20
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
3,208,376

Security key

702712100

Report period

Q2 2024

Institutions

41

Top holders

10

Ownership snapshot

Top reported holders of PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Erste Asset Management GmbH
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F 13D/G Lead comparable stake: 4.4% 13D/G row: Erste Asset Management GmbH Showing 1-6 of 15 holder rows.

Quick read

Erste Asset Management GmbH leads the comparable SEC ownership view at 4.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Erste Asset Management GmbH's linked filing trail.
Comparable ownership Top 5
Erste Asset Management GmbH 4.4%
ORBIMED ADVISORS LLC 316%
Versant Venture Management, LLC 155%
Lynx1 Capital Management LP 151%
Vestal Point Capital, LP 140%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Erste Asset Management GmbH
13F 13D/G
Company
4.4%
from 13D/G
$3,313,098
2,455,800 shares
31 Mar 2024
ORBIMED ADVISORS LLC
13F
Company
13F
316%
$13,668,178
10,124,576 shares
31 Mar 2024
Versant Venture Management, LLC
13F
Company
13F
155%
$6,695,688
4,959,769 shares
31 Mar 2024
Lynx1 Capital Management LP
13F
Company
13F
151%
$6,541,926
4,845,871 shares
31 Mar 2024
Vestal Point Capital, LP
13F
Company
13F
140%
$6,075,000
4,500,000 shares
31 Mar 2024
New Leaf Venture Partners, L.L.C.
13F
Company
13F
78%
$3,372,195
2,497,922 shares
31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
41
Shares
40,276,764
Rows available
41
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
47
Q2 2024 holders
41
Holder diff
-6
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .